Investigation of radiation-induced transcriptome profile of radioresistant non-small cell lung cancer A549 cells using RNA-seq
- PMID: 23533613
- PMCID: PMC3606344
- DOI: 10.1371/journal.pone.0059319
Investigation of radiation-induced transcriptome profile of radioresistant non-small cell lung cancer A549 cells using RNA-seq
Abstract
Radioresistance is a main impediment to effective radiotherapy for non-small cell lung cancer (NSCLC). Despite several experimental and clinical studies of resistance to radiation, the precise mechanism of radioresistance in NSCLC cells and tissues still remains unclear. This result could be explained by limitation of previous researches such as a partial understanding of the cellular radioresistance mechanism at a single molecule level. In this study, we aimed to investigate extensive radiation responses in radioresistant NSCLC cells and to identify radioresistance-associating factors. For the first time, using RNA-seq, a massive sequencing-based approach, we examined whole-transcriptome alteration in radioresistant NSCLC A549 cells under irradiation, and verified significant radiation-altered genes and their chromosome distribution patterns. Also, bioinformatic approaches (GO analysis and IPA) were performed to characterize the radiation responses in radioresistant A549 cells. We found that epithelial-mesenchymal transition (EMT), migration and inflammatory processes could be meaningfully related to regulation of radiation responses in radioresistant A549 cells. Based on the results of bioinformatic analysis for the radiation-induced transcriptome alteration, we selected seven significant radiation-altered genes (SESN2, FN1, TRAF4, CDKN1A, COX-2, DDB2 and FDXR) and then compared radiation effects in two types of NSCLC cells with different radiosensitivity (radioresistant A549 cells and radiosensitive NCI-H460 cells). Interestingly, under irradiation, COX-2 showed the most significant difference in mRNA and protein expression between A549 and NCI-H460 cells. IR-induced increase of COX-2 expression was appeared only in radioresistant A549 cells. Collectively, we suggest that COX-2 (also known as prostaglandin-endoperoxide synthase 2 (PTGS2)) could have possibility as a putative biomarker for radioresistance in NSCLC cells.
Conflict of interest statement
Figures
Similar articles
-
ITGB1 enhances the Radioresistance of human Non-small Cell Lung Cancer Cells by modulating the DNA damage response and YAP1-induced Epithelial-mesenchymal Transition.Int J Biol Sci. 2021 Jan 18;17(2):635-650. doi: 10.7150/ijbs.52319. eCollection 2021. Int J Biol Sci. 2021. PMID: 33613118 Free PMC article.
-
miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.Biosci Rep. 2020 Jul 31;40(7):BSR20192795. doi: 10.1042/BSR20192795. Biosci Rep. 2020. PMID: 32364222 Free PMC article.
-
Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells.Int J Mol Sci. 2023 Feb 3;24(3):3042. doi: 10.3390/ijms24033042. Int J Mol Sci. 2023. PMID: 36769365 Free PMC article.
-
Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.Chin J Cancer. 2016 Jun 7;35:50. doi: 10.1186/s40880-016-0113-3. Chin J Cancer. 2016. PMID: 27266881 Free PMC article.
-
CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.Cell Commun Signal. 2020 Sep 17;18(1):152. doi: 10.1186/s12964-020-00571-4. Cell Commun Signal. 2020. PMID: 32943060 Free PMC article.
Cited by
-
Differentially Expressed mRNAs and Potential Mechanisms of Radiation-Induced TUT4-/- Esophageal Cell Injury.Dose Response. 2022 Oct 27;20(4):15593258221136810. doi: 10.1177/15593258221136810. eCollection 2022 Oct-Dec. Dose Response. 2022. PMID: 36324561 Free PMC article.
-
Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.Ecancermedicalscience. 2016 Oct 12;10:680. doi: 10.3332/ecancer.2016.680. eCollection 2016. Ecancermedicalscience. 2016. PMID: 27899953 Free PMC article.
-
Overexpression of TRAF4 promotes lung cancer growth and EGFR-dependent phosphorylation of ERK5.FEBS Open Bio. 2022 Oct;12(10):1747-1760. doi: 10.1002/2211-5463.13458. Epub 2022 Aug 17. FEBS Open Bio. 2022. PMID: 35748027 Free PMC article.
-
DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses.Tumour Biol. 2016 Oct;37(10):14183-14191. doi: 10.1007/s13277-016-5203-y. Epub 2016 Aug 23. Tumour Biol. 2016. PMID: 27553023 Free PMC article.
-
DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib.Cell Death Discov. 2024 Sep 27;10(1):411. doi: 10.1038/s41420-024-02188-9. Cell Death Discov. 2024. PMID: 39333096 Free PMC article.
References
-
- Yin ZJ, Jin FG, Liu TG, Fu EQ, Xie YH, et al. (2011) Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells. J Surg Res 171: 675–683. - PubMed
-
- Shin S, Cha HJ, Lee EM, Lee SJ, Seo SK, et al. (2009) Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int J Oncol 35: 81–86. - PubMed
-
- Kim W, Youn H, Seong KM, Yang HJ, Yun YJ, et al. (2011) PIM1-activated PRAS40 regulates radioresistance in non-small cell lung cancer cells through interplay with FOXO3a, 14-3-3 and protein phosphatases. Radiat Res 176: 539–552. - PubMed
-
- Liang K, Ang KK, Milas L, Hunter N, Fan Z (2003) The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys 57: 246–254. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous